91 related articles for article (PubMed ID: 1656181)
1. [Effect of erythropoietin therapy on alpha receptor density in chronic dialysis patients].
Fritschka E; Neumayer HH; Seddighi S; Distler A; Philipp T
Med Klin (Munich); 1991 Jul; 86(7):353-9. PubMed ID: 1656181
[TBL] [Abstract][Full Text] [Related]
2. Effect of erythropoietin on parameters of sympathetic nervous activity in patients undergoing chronic haemodialysis.
Fritschka E; Neumayer HH; Seddighi S; Thiede HM; Distler A; Philipp T
Br J Clin Pharmacol; 1990; 30 Suppl 1(Suppl 1):135S-138S. PubMed ID: 2176518
[TBL] [Abstract][Full Text] [Related]
3. [Recombinant human erythropoietin (rh-EPO) in chronic, dialysis-dependent renal failure: effects on macro- and microcirculation and hematologic parameters].
Köhler M; Mörsdorf S; Jung F; Braun B; Waldhausen P; Pindur G; Weber U; Bosslet R; Bambauer R; Jutzler GA
Beitr Infusionsther; 1990; 26():89-95. PubMed ID: 1703909
[TBL] [Abstract][Full Text] [Related]
4. [Influence of long-term human recombinant erythropoietin treatment on secretion of pancreatic polypeptide and gastrin in hemodialysed patients with chronic renal failure].
Nieszporek T; Kokot F; Wiecek A; Marcinkowski W; Rudka R; Trembecki J
Przegl Lek; 1995; 52(12):590-3. PubMed ID: 8834657
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte 5'-nucleotidase and aminopeptidase N activity in patients on maintenance hemodialysis treated with human recombinant erythropoietin and 1-alpha-D3.
Stefanovic V; Mitić-Zlatkovic M; Radivojevic J; Vlahovic P
Ren Fail; 2005; 27(3):283-8. PubMed ID: 15957544
[TBL] [Abstract][Full Text] [Related]
6. Increased density and responsiveness of alpha 2 and beta-adrenoceptors in circulating blood cells of essential hypertensive patients.
Brodde OE; Daul A; O'Hara N; Bock KD
J Hypertens Suppl; 1984 Dec; 2(3):S111-4. PubMed ID: 6100731
[TBL] [Abstract][Full Text] [Related]
7. Changes in the alpha adrenergic system and increase in blood pressure with recombinant human erythropoietin (rHuEpo) therapy for renal anemia.
Müller R; Steffen HM; Brunner R; Saric J; Pollok M; Baldamus CA; Kaufmann W
Clin Invest Med; 1991 Dec; 14(6):614-22. PubMed ID: 1665406
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of anemia in chronic hemodialysis patients with recombinant human erythropoietin: long-term results in 15 patients].
Jacquot C; Berthelot JM; Chiappini-Judith D; Ferragu-Haguet M; Lefebvre A; Masselot JP; Moynot A; Frydman MO; Peterlongo F
Nephrologie; 1990; 11(1):11-6. PubMed ID: 2374641
[TBL] [Abstract][Full Text] [Related]
9. [The effect of hemodialysis on levels of beta-endorphin in serum of patients with chronic renal failure treated with erythropoietin].
Burak W; Grzeszczak W; Trelewicz P; Zukowska-Szczechowska E
Przegl Lek; 1996; 53(2):54-7. PubMed ID: 8754321
[TBL] [Abstract][Full Text] [Related]
10. Decreased number of alpha-adrenergic receptors in platelets of patients on maintenance haemodialysis.
Brodde OE; Daul A; Graben N
Proc Eur Dial Transplant Assoc; 1983; 19():270-4. PubMed ID: 6308599
[TBL] [Abstract][Full Text] [Related]
11. Effect of recombinant human erythropoietin therapy on ambulatory blood pressure in normotensive and in untreated borderline hypertensive hemodialysis patients.
Lebel M; Kingma I; Grose JH; Langlois S
Am J Hypertens; 1995 Jun; 8(6):545-51. PubMed ID: 7662237
[TBL] [Abstract][Full Text] [Related]
12. Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients.
Khosroshahi HT; Shoja MM; Tubbs RS; Estakhri R; Ardalan MR
Transplant Proc; 2007 May; 39(4):1051-3. PubMed ID: 17524889
[TBL] [Abstract][Full Text] [Related]
13. [Effect of recombinant human erythropoietin administration on cardiovascular system in patient with chronic renal failure: an analysis of the blood pressure upward].
Satoh K; Ikeda Y; Kurokawa S; Kamata K; Masuda T; Kikawada R; Marumo F
Kokyu To Junkan; 1989 Mar; 37(3):313-9. PubMed ID: 2734509
[TBL] [Abstract][Full Text] [Related]
14. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
Nissenson AR
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
[TBL] [Abstract][Full Text] [Related]
15. [Effect of recombinant human erythropoietin--rHu-EPO on the metabolism of children treated by long-term hemodialysis].
Pietrzyk JA; Smolnik T; Szymowska M; Dyras P; Lenik J
Przegl Lek; 1992; 49(1-2):55-60. PubMed ID: 1455008
[TBL] [Abstract][Full Text] [Related]
16. Regulation of alpha 2-adrenoceptor density in normotensive and hypertensive man.
Fritschka E; Kribben A; Hoyer J; Rothschild M; Thiede HM; Distler A; Philipp T
J Hypertens Suppl; 1987 Dec; 5(5):S349-52. PubMed ID: 2832574
[TBL] [Abstract][Full Text] [Related]
17. [Anemia management in haemodialysis. EuCliD database in Spain].
Avilés B; Coronel F; Pérez-García R; Marcelli D; Orlandini G; Ayala JA; Rentero R
Nefrologia; 2002; 22(6):555-63. PubMed ID: 12516289
[TBL] [Abstract][Full Text] [Related]
18. The cardiovascular and hemodynamic effects of erythropoietin in chronic renal failure.
Singh NP; Chandrashekhar ; Nair M; Anuradha S; Kohli R; Agarwal SK
J Assoc Physicians India; 2000 Mar; 48(3):301-6. PubMed ID: 11229114
[TBL] [Abstract][Full Text] [Related]
19. Changes in diurnal blood pressure variation and red cell and plasma volumes in patients with renal failure who develop erythropoietin-induced hypertension.
Jones MA; Kingswood JC; Dallyn PE; Andrew M; Cheetham A; Burwood R; Sharpstone P
Clin Nephrol; 1995 Sep; 44(3):193-200. PubMed ID: 8556836
[TBL] [Abstract][Full Text] [Related]
20. [The effect of recombinant erythropoietin on candidicidal activity of polymorphonuclear leukocytes in hemodialyzed patients].
Bartůnková J; Sulková S; Cebecauer M
Cas Lek Cesk; 1995 Dec; 134(23):756-9. PubMed ID: 8599817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
